| Deng R
Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. [Journal Article]
Cardiovasc Drug Rev 2007; 25(4):375-90.
Abstract | Full Citation | Find Related Articles |
| Jakubowski JA, Winters KJ, Naganuma H, et al.
Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile. [Journal Article]
Cardiovasc Drug Rev 2007; 25(4):357-74.
Abstract | Full Citation | Find Related Articles |
| Tanaka H, Hashimoto N
A Multiple Ion Channel Blocker, NIP-142, for the Treatment of Atrial Fibrillation. [Journal Article]
Cardiovasc Drug Rev 2007; 25(4):342-56.
Abstract | Full Citation |
| Akao M, Takeda T, Kita T, et al.
Serofendic Acid, a substance extracted from fetal calf serum, as a novel drug for cardioprotection. [Journal Article]
Cardiovasc Drug Rev 2007; 25(4):333-41.
Abstract | Full Citation | Find Related Articles |
| Kirtane AJ, Leon MB
Clinical use of sirolimus-eluting stents. [Journal Article]
Cardiovasc Drug Rev 2007; 25(4):316-32.
Abstract | Full Citation | Find Related Articles |
| Zeymer U, Wienbergen H
A review of clinical trials with eptifibatide in cardiology. [Journal Article]
Cardiovasc Drug Rev 2007; 25(4):301-15.
Abstract | Full Citation | Find Related Articles |
| Godfrey V, Chan SL, Cassidy A, et al.
The functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthy volunteers. [Clinical Trial, Journal Article]
Cardiovasc Drug Rev 2007; 25(3):280-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Ali F, Raufi MA, Washington B, et al.
Conivaptan: a dual receptor vasopressin v(1a)/v(2) antagonist. [Journal Article]
Cardiovasc Drug Rev 2007; 25(3):261-79.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Pacher P, Szabó C
Role of Poly(ADP-ribose) polymerase 1 (PARP-1) in Cardiovascular Diseases: The Therapeutic Potential of PARP Inhibitors. [Journal Article]
Cardiovasc Drug Rev 2007; 25(3):235-60.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Hoel AW, Conte MS
Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass. [Journal Article]
Cardiovasc Drug Rev 2007; 25(3):221-34.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
